Tech Company Financing Transactions
Click Therapeutics Funding Round
Click Therapeutics secured a $17 million investment round on 7/24/2018. Backers included Sanofi-Genzyme BioVentures and private investors.
Transaction Overview
Company Name
Announced On
7/24/2018
Transaction Type
Venture Equity
Amount
$17,000,000
Round
Undisclosed
Investors
Sanofi-Genzyme BioVentures (Lead Investor) (Bernard Davitian)
Proceeds Purpose
Click will use this financing to continue advancing its proprietary platform and pipeline of prescription digital therapeutics to treat a wide range of diseases. Recent notes were converted to equity as part of the financing.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
101 Ave. of the Americas 8th Floor
New York, NY 10013
USA
New York, NY 10013
USA
Phone
Website
Email Address
Overview
Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click's Digital Therapeutics enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Klein
Chief Financial Officer
Randall Stanicky
Chief Technical Officer
Han Chiu
VP - Bus. Development
Richard DeNunzio
VP - Bus. Development
Marcus Panzitta
VP - Bus. Development
Austin Speier
VP - Customer Service
Charles Niesenbaum
VP - Engineering
Ritesh Manchanda
VP - Engineering
Michael Ng
VP - Finance
Lisa Chen
VP - General Counsel
Tarique Collins
VP - Human Resources
Heather Knigin
VP - Marketing
Jasmine Neveles
VP - Operations
Cathleen Platt
VP - Product Management
Daniel Rimm
VP - R & D
Shaheen Lakhan
Browse more venture capital transactions:
Prev: 7/24/2018: Brightpearl venture capital transaction
Next: 7/24/2018: Avinger venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs